鈴木 利貴央

Suzuki Rikio

  • 准教授
  • 学位:博士(医学)

基本情報

所属

  • Undergraduate School of Medicine / Faculty of Medicine

詳細情報

研究分野

  • Life sciences Hematology and oncology Multiple myeloma

受賞

  • 2013 ASH Abstract Achievement Award

論文

Coexistence of monomorphic epitheliotropic intestinal T-cell lymphoma of the jejunum and bilateral adrenal pheochromocytomas: A case report

Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes.

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient.

高リスクAML/MDSに対する超低用量メソトレキセートを用いた臍帯血移植の有用性

難治性肝脾T細胞リンパ腫に対して臍帯血移植後のタゼメトスタットが奏効した一例

ALK-negative anaplastic large cell lymphoma with TP53 mutation developing during the administration of baricitinib for atopic dermatitis - A case report.

HLAエピトープ不一致が臍帯血移植成績に与える影響

移植前のキザルチニブ併用全脳全脊椎照射が有効であった中枢神経浸潤を伴うFLT3-ITD変異陽性AML

乳癌治療後に発症したZMYND11::MBTD1融合遺伝子を有する急性白血病

Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR-T cell manufacturing failure in myeloma

Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferation.

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report.

[Disseminated toxoplasmosis after cord blood transplantation diagnosed at autopsy].

ステロイド依存性/難治性cGVHDに対するibrutinibの有効性 単施設後方視的検討

同種造血幹細胞移植を施行したT細胞性リンパ腫の単施設後方視的解析

Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia.

Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma.

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma.

共同研究・競争的資金等の研究課題

Development of a novel minimally invasive treatment for refractory and therapy-resistant hematological malignancies using food extracts.

Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.

Elucidation and overcoming of drug resistance mechanism mediated by semaphorin 3A signal in multiple myeloma

ResearchMapへ移動します

Contact Us

Inquiries about coverage

Public Affairs Division Public Affairs and Communications Department

Tel. 0463-63-4670(direct dialing)